Dermatology CDI

Toxic Epidermal Necrolysis (TEN) is distinguished from SJS in 2026 audits by having:

For a diagnosis of Ichthyosis, senior-level documentation must distinguish between:

To differentiate between non-melanoma skin cancers for 2026 coding, document:

When documenting "Seborrheic Dermatitis," the audit requirement is to specify the site and if it is:

For a diagnosis of "Morbus Morbihan" (Solid Facial Edema), documentation must link it to:

To trigger accurate coding for "Dermatomyositis," the documentation must specify if there is:

Vitiligo documentation in 2026 must specify if the pattern is:

When documenting eczema, the clinician must differentiate between:

Common warts (Verruca Vulgaris) must be documented with the specific:

When documenting a non-pressure chronic ulcer, the senior-level requirement is to specify the:

For a diagnosis of Ichthyosis, senior-level documentation must distinguish between:

When documenting a benign nevus (mole), 2026 specificity requires the anatomical site and:

Lipoma documentation requires the anatomical site and the specific:

To accurately code "Calciphylaxis" in 2026, documentation must link the skin necrosis to:

Documentation of "Granuloma Annulare" (L92.0) must specify if the presentation is:

Scabies documentation must specify if the condition is "Classic" or:

For pre-cancerous solar damage, senior documentation must specify Actinic Keratosis and if it is:

Chronic abscesses in the axilla or groin should be documented with the Hurley Stage and the diagnosis:

Fungal infections of the skin (Tinea) must be documented with the specific:

Which diagnosis represents a high-severity (MCC) autoimmune blistering condition?

To differentiate between raised scars, senior documentation must specify:

Malignant Melanoma documentation must include the anatomical site, laterality, and the:

Audit-level documentation for a pressure injury (L89.-) must include the anatomical site and the:

Stevens-Johnson Syndrome (SJS) requires the documentation of the specific drug trigger and the:

Shingles documentation must specify the anatomical site and the presence of:

To trigger a risk adjustment (HCC) for autoimmune blistering, document the specific site and:

To accurately code "Panniculitis," documentation must specify the anatomical site and the type:

Which documentation is required to specify the type of Psoriasis for accurate coding?

Senior documentation for "Necrobiosis Lipoidica" (L92.1) must specify if the patient has:

Audit-level documentation for Onychomycosis (nail fungus) requires:

For the removal of Seborrheic Keratosis (SK), medical necessity is established by documenting if it is:

To avoid "unspecified" rosacea codes, document the subtype (e.g., Papulopustular) or if it is:

When documenting "Pruritus" (Itching), the clinician must specify the underlying cause or if it is:

For a drug-related skin reaction, the senior documentation requirement is the morphology and:

Acne documentation requires the specificity of the type (e.g., Vulgaris) and the:

Small, umbilicated "water warts" caused by a poxvirus are documented as:

To accurately code a skin infection under 2026 rules, the clinician must distinguish between:

When documenting a drug-induced photosensitivity reaction, the senior requirement is to specify:

To differentiate between types of "Hives" for audit-level coding, document:

Audit-level documentation for "Pyoderma Gangrenosum" (L88) requires the presence of:

Hair loss documentation must differentiate between Alopecia Areata and:

Impetigo documentation should include the morphology (Bullous vs. Non-bullous) and the:

For the diagnosis of "Lichen Planus," the clinician must specify the anatomical site and the:

To trigger a risk adjustment (HCC) factor for a patient with skin and joint disease, document:

Documentation for "Pityriasis Rosea" should include the presence of the: